[1]
|
Duan, X., Chen, P., Xu, X., Han, M. and Li, J. (2022) Role of Gastric Microorganisms Other than Helicobacter pylori in the Development and Treatment of Gastric Diseases. BioMed Research International, 2022, Article ID: 6263423.
https://doi.org/10.1155/2022/6263423
|
[2]
|
Koga, Y. (2022) Microbiota in the Stomach and Application of Probi-otics to Gastroduodenal Diseases. World Journal of Gastroenterology, 28, 6702-6715. https://doi.org/10.3748/wjg.v28.i47.6702
|
[3]
|
Xing, Y., Gu, X., Ruan, G. and Chen, S. (2022) Probiotics for the Treatment of Gastric Diseases. Nutrition and Cancer, 74, 3051-3057. https://doi.org/10.1080/01635581.2022.2067335
|
[4]
|
Yang, I., Nell, S. and Suerbaum, S. (2013) Survival in Hos-tile Territory: The Microbiota of the Stomach. FEMS Microbiology Reviews, 37, 736-761. https://doi.org/10.1111/1574-6976.12027
|
[5]
|
Bessède, E. and Mégraud, F. (2022) Microbiota and Gastric Cancer. Seminars in Cancer Biology, 86, 11-17.
https://doi.org/10.1016/j.semcancer.2022.05.001
|
[6]
|
Langille, M.G., Zaneveld, J., Caporaso, J.G., McDonald, D., Knights, D., Reyes, J.A., Clemente, J.C., Burkepile, D.E., Vega Thurber, R.L., Knight, R., Beiko, R.G. and Huttenhower, C. (2013) Predictive Functional Profiling of Microbial Communities Using 16S rRNA Marker Gene Sequences. Nature Biotechnology, 31, 814-821.
https://doi.org/10.1038/nbt.2676
|
[7]
|
Coker, O.O., Dai, Z., Nie, Y., Zhao, G., Cao, L., Nakatsu, G., Wu, W.K., Wong, S.H., Chen, Z., Sung, J.J.Y. and Yu, J. (2017) Mucosal Microbiomedysbiosis in Gastric Carcinogenesis. Gut, 67, 1024-1032.
https://doi.org/10.1136/gutjnl-2017-314281
|
[8]
|
Nasr, R., Shamseddine, A., Mukherji, D., Nassar, F. and Temraz, S. (2020) The Crosstalk between Microbiome and Immune Response in Gastric Cancer. International Journal of Molec-ular Sciences, 21, 6586.
https://doi.org/10.3390/ijms21186586
|
[9]
|
Liu, X., Shao, L., Liu, X., Ji, F., Mei, Y., Cheng, Y., Liu, F., Yan, C., Li, L. and Ling, Z. (2019) Alterations of Gastric Mucosal Microbiota across Different Stomach Microhabitats in a Cohort of 276 Patients with Gastric Cancer. eBioMedicine, 40, 336-348. https://doi.org/10.1016/j.ebiom.2018.12.034
|
[10]
|
Zong, L., Li, H. and Li, S. (2019) Effects of Neoadjuvant Chem-otherapy Combined with Enteral Nutrition on Perioperative Immunity, Inflammation and Intestinal Flora in Gastric Can-cer Patients. Journal of BUON, 24, 1113-1119.
|
[11]
|
Zhou, G. and Yang, J. (2019) Correlations of Gastrointestinal Hormones with Inflammation and Intestinal Flora in Patients with Gastric Cancer. Journal of BUON, 24, 1595-1600.
|
[12]
|
Wang, F., Meng, W., Wang, B. and Qiao, L. (2014) Helicobacter pylori-Induced Gastric Inflammation and Gastric Cancer. Cancer Letters, 345, 196-202. https://doi.org/10.1016/j.canlet.2013.08.016
|
[13]
|
Fakharian, F., Asgari, B., Nabavi-Rad, A., Sadeghi, A., Soleimani, N., Yadegar, A. and Zali, M.R. (2022) The Interplay between Heli-cobacter pylori and the Gut Microbiota: An Emerging Driver Influencing the Immune System Homeostasis and Gastric Carcinogenesis. Frontiers in Cellular and Infection Microbiology, 12, Article ID: 953718.
https://doi.org/10.3389/fcimb.2022.953718
|
[14]
|
Liu, Y., Baba, Y., Ishimoto, T., Gu, X., Zhang, J., Nomoto, D., Okadome, K., Baba, H. and Qiu, P. (2022) Gut Microbiome in Gastrointestinal Cancer: A Friend or Foe? International Journal of Biological Sciences, 18, 4101-4117.
https://doi.org/10.7150/ijbs.69331
|
[15]
|
O’Callaghan, A. and van Sinderen, D. (2016) Bifidobacteria and Their Role as Members of the Human Gut Microbiota. Frontiers in Microbiology, 7, 925. https://doi.org/10.3389/fmicb.2016.00925
|
[16]
|
Dou, Y., Yu, X., Luo, Y., Chen, B., Ma, D. and Zhu, J. (2022) Ef-fect of Fructooligosaccharides Supplementation on the Gut Microbiota in Human: A Systematic Review and Me-ta-Analysis. Nutrients, 14, 3298.
https://doi.org/10.3390/nu14163298
|
[17]
|
Wang, Y., Song, W., Yu, S., Liu, Y. and Chen, Y.G. (2022) Intestinal Cellular Heterogeneity and Disease Development Revealed by Single-Cell Technology. Cell Regeneration, 11, Article No. 26.
https://doi.org/10.1186/s13619-022-00127-6
|
[18]
|
Fakharian, F., Asgari, B., Nabavi-Rad, A., Sadeghi, A., So-leimani, N., Yadegar, A. and Zali, M.R. (2022) The Interplay between Helicobacter pylori and the Gut Microbiota: An Emerging Driver Influencing the Immune System Homeostasis and Gastric Carcinogenesis. Frontiers in Cellular and Infection Microbiology, 12, Article ID: 953718.
https://doi.org/10.3389/fcimb.2022.953718
|